Santo et al. “Antimyeloma Activity of a Multitargeted Kinase Inhibitor, AT9283, via Potent Aurora Kinase and STAT3 Inhibition Either Alone or in Combination with Lenalidomide.” Clinical Cancer Research 17, no. 10 2011: 3259–71. DOI: 10.1158/1078-0432.CCR-10-3012.
Santo et al. “Antimyeloma Activity of a Multitargeted Kinase Inhibitor, AT9283, via Potent Aurora Kinase and STAT3 Inhibition Either Alone or in Combination with Lenalidomide.” Clinical Cancer Research 17, no. 10 2011: 3259–71. DOI: 10.1158/1078-0432.CCR-10-3012.
